Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
6.54M
-
Shares change
-
+80.1K
-
Total reported value, excl. options
-
$422M
-
Value change
-
+$7.86M
-
Put/Call ratio
-
6.22
-
Number of buys
-
68
-
Number of sells
-
-65
-
Price
-
$64.45
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2017
175 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2017.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.54M shares
of 22.3M outstanding shares and own 29.37% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.27M shares), Vanguard Group Inc (481K shares), DIMENSIONAL FUND ADVISORS LP (456K shares), MANGROVE PARTNERS (376K shares), Invesco Ltd. (291K shares), NOMURA HOLDINGS INC (284K shares), STATE STREET CORP (284K shares), RENAISSANCE TECHNOLOGIES LLC (233K shares), Bank of New York Mellon Corp (191K shares), and DEUTSCHE BANK AG\ (160K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.